TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Buckman Laboratories AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
11,009
|
15,689
|
16,406 |
| Financial expenses |
444
|
54
|
198 |
| Earnings before taxes |
-579
|
422
|
530 |
| EBITDA |
-17
|
568
|
434 |
| Total assets |
5,164
|
6,716
|
7,261 |
| Current assets |
4,974
|
6,398
|
6,910 |
| Current liabilities |
4,264
|
5,113
|
5,419 |
| Equity capital |
899
|
1,603
|
1,842 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
17.4%
|
23.9%
|
25.4% |
| Turnover per employee |
5,504
|
7,844
|
8,203 |
| Profit as a percentage of turnover |
-5.3%
|
2.7%
|
3.2% |
| Return on assets (ROA) |
-2.6%
|
7.1%
|
10.0% |
| Current ratio |
116.7%
|
125.1%
|
127.5% |
| Return on equity (ROE) |
-64.4%
|
26.3%
|
28.8% |
| Change turnover |
-4,161
|
-802
|
2,823 |
| Change turnover % |
-27%
|
-5%
|
21% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.